SCHEDULE: FMR LLC Holds 13.2% Stake in Twist Bioscience

FMR LLC, along with Abigail P. Johnson, has reported a beneficial ownership of 13.2% of Twist Bioscience Corp.'s common stock as of August 31, 2026.

Summary

• FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting their beneficial ownership of Twist Bioscience Corp. common stock.
• As of August 31, 2026, FMR LLC beneficially owns 8,760,081.45 shares, representing 13.2% of the class of securities.
• Abigail P. Johnson is identified as a Director, Chairman, and CEO of FMR LLC, and members of the Johnson family are predominant owners of FMR LLC's voting shares.
• The filing indicates that FMR LLC and its subsidiaries, along with other entities, are collectively referred to as 'FMR Reporters'.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant but stable institutional holding rather than a new development or change in strategy.

Positives

• FMR LLC's substantial holding of 13.2% indicates significant institutional confidence in Twist Bioscience Corp.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a long-term investment perspective.

Negatives

• The filing is an amendment to a previous filing, suggesting a change or update in holdings, though the exact nature of the change isn't detailed here.
• No specific new investment or divestment activity is detailed, making it a status update rather than a strategic move.

Risks

• The filing does not explicitly mention any risks associated with the holding or the company itself.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future performance or strategy.

Management Comments

• FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors reporting significant stakes. FMR LLC is a major financial services firm, and its holdings in a biotech company like Twist Bioscience Corp. reflect ongoing institutional interest in the sector.

Comparison to Industry Standards

• As a Schedule 13G filing, it reports beneficial ownership by institutional investors. FMR LLC's 13.2% stake is a substantial holding, often indicative of a significant investment by a fund manager or asset management firm in a publicly traded company.
• Industry standards for institutional ownership vary by sector, but a stake of this size in a mid-cap or small-cap company like Twist Bioscience Corp. is generally considered significant.

Related Party Transactions

• Abigail P. Johnson, as Director, Chairman, and CEO of FMR LLC, is involved in the management of the entity reporting the beneficial ownership.
• Members of the Johnson family are predominant owners of FMR LLC's voting shares and have entered into a shareholders' voting agreement.

Stakeholder Impact

• Shareholders: The continued significant institutional holding by FMR LLC may provide a degree of stability to the stock price and signal investor confidence.
• Management: The filing confirms that the holding is for ordinary course of business, not for control, which is a standard assurance to management and the board.

Next Steps

• FMR LLC and Abigail P. Johnson will continue to hold their beneficial ownership of Twist Bioscience Corp. common stock.
• Future amendments to this filing would be required if there are material changes in beneficial ownership.

Key Dates

Keywords

FMR LLC, Abigail P. Johnson, Twist Bioscience Corp, Schedule 13G, Beneficial Ownership, Institutional Holding, Common Stock